Pituitary & hypothalamus

Fluid Restriction Reduces Delayed Hyponatremia and Hospital Readmissions After Transsphenoidal Surgery

J Clin Endocrinol MetabPublished Retrospective and prospective cohort study

Main finding · Delayed hyponatremiaResult — go to the resultRelative risk 0.52

Authors' conclusion

Restricting fluid to 1 L/day on discharge decreases rates of delayed hyponatremia and readmissions by 50%. Standardized patient education and POD 7 sodium testing decreases severity of hyponatremia but does not impact readmission rates. These protocols should be considered standard practice for patients undergoing transsphenoidal surgery.

Study context

Population
Patients undergoing transsphenoidal surgery for pituitary adenomas and other sellar and parasellar pathologies, tertiary referral hospital
Participants
296 / 316 / 110
Exposure
Phase 1 vs phase 2 vs phase 3
  • Phase 1n = 296reference
  • Phase 2n = 316
  • Phase 3n = 110
Outcome
Rates of early and delayed hyponatremia and readmissions
Methodological detailstwo retrospective analyses and 1 prospective study, single-centre
  • Two retrospective analyses and 1 prospective study
  • Single-centre

Main finding

Delayed hyponatremia

Relative risk

0.52

By group

As reported in the abstract

Observational data: associations, not effects.

Secondary outcomes

OutcomePhase 2Phase 3RR (CI)
ReadmissionsPhase 3vs Phase 1Readmissions reduced 3-fold— not stated in the abstract4.6%0.30 (0.12–0.73)

— not stated in the abstract

OutcomePhase 2Phase 3
Early hyponatremia22%— not stated in the abstract
Compliance with POD 7 sodium testing89%— not stated in the abstract

— not stated in the abstract

Readmissions

Phase 3: readmissions for hyponatremia markedly reduced
Phase 2: readmissions unchanged

Severity of hyponatremia

Phase 2: severity of hyponatremia reduced
60%

Readmission costs

Hyponatremia readmission increased costs
30%

Original publication

Fluid Restriction Reduces Delayed Hyponatremia and Hospital Readmissions After Transsphenoidal Surgery. J Clin Endocrinol Metab. Published 1 February 2023. doi:10.1210/clinem/dgad066

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.